Corcept Therapeutics, Inc. (CORT) Misses Q1 Loss views by 2c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $117.17 +2.36%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q1 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
- Is Treasury selloff a major issue for stock market bulls?
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
